While the concept of reduced GR function and expression leading to ‘glucocorticoid resistance’ in depression has been extensively discussed before51–55, including for TRD patients56–58, the present study shows that reduced GR mRNA expression alone cannot fully explain the increased inflammation. Here, NR3C1 is linked to depressive symptom measurement.